History of Female Hormone Replacement

History of Female Hormone Replacement

What if the study that scared an entire generation of women away from hormone replacement therapy was fundamentally flawed — and the fallout lasted twenty years? Rick and Greg sit down with Caitlin Robinson, NP, to trace the full arc of female HRT: from the optimism of the 1960s through the 2002 Women's Health Initiative study that brought it to a hard stop, to the slow, ongoing rehabilitation of the science. Caitlin breaks down the three core problems with the WHI — wrong patients (mostly women over 60, a decade past menopause), wrong medications (synthetic hormones instead of bioidenticals), and a misreading of risk that got amplified by media coverage into something close to panic. She explains what bioidentical hormones actually are, why women's hormonal balance is more complex than a single testosterone number, and what the current consensus looks like for timing, candidacy, and individualized care. They also get honest about the downstream cost: women who lost years of quality of life, a generation of older women with fragile bones and metabolic disease, and primary care providers still practicing off guidelines written in the shadow of a flawed study. This is Part 1 of a multi-episode series on women's hormonal health. For informational purposes only — not medical advice. Talk to your provider.

Treating the Testosterone Lows

Most guys know something's off — they just can't name it. In this episode, Rick and Greg break down what to actually do about low testosterone: the lifestyle foundation that has to come first, the supplements worth considering (including why boron is getting more attention than it used to), and the three medication-based options your provider might discuss — SERMs, HCG, and full testosterone replacement therapy. They also walk through the difference between total and free testosterone, why you can have a "normal" number and still feel terrible, and why medication without the foundation is a losing game. If you've been dragging, or you know someone who has, this is the episode. Ladies, this one's for your husbands too. Topics covered: sleep, resistance training, HIIT, nutrition, vitamin D, zinc, boron, sex hormone binding globulin, clomiphene, enclomiphene, HCG/Pregnyl, testosterone replacement therapy (injections and creams), LH/FSH signaling, cortisol and stress, and how to structure the conversation with your medical provider. For informational and educational purposes only. Consult your licensed medical provider before beginning any hormone therapy, supplement, medication, or lifestyle program.

The Insidious Testosterone Crisis

In this episode, Rick and Greg turn their focus to men's health — specifically the quiet, decades-long decline in testosterone levels and why so many men are being told they're "fine" when they're anything but. They walk through the classic patient story that Greg hears constantly in the clinic: a man in his forties or fifties, gaining weight in the midsection, losing muscle despite working out, mentally foggy, low energy, increasingly irritable — and sent home with a normal lab result and a shrug. Rick and Greg explain why total testosterone alone is an incomplete picture, how the standard advice of "just be more active" can actually work against men with low T, and why this is a cyclical, compounding problem that gets harder to escape the longer it goes unaddressed. They also get into the broader science: how testosterone connects to visceral fat, insulin sensitivity, metabolic function, and overall quality of life — and why framing it as just a "sex hormone" or a bodybuilder drug has led to years of under-diagnosis and dismissal. This is part one of a multi-episode series on hormones. Next episode: symptoms to watch for, what age to start checking, and the full range of treatment options beyond injectable testosterone. Rick and Greg are medical providers, but not your medical provider. Consult your personal provider before starting any medication, hormone therapy, or health program.

GLP-1 Cheating Myths Debunked

Rick and Greg take a detour from their upcoming hormones series to address a topic that comes up constantly in the clinic: the stigma surrounding GLP-1 medications for weight loss. If you've ever heard — or thought — "they took the easy way out," this episode is for you. They walk through the most common myths about medication-assisted weight loss, explain why these beliefs are medically unfounded, and explore the real-world consequences of that stigma: people delaying or avoiding treatment for a legitimate chronic disease. The guys also reference a recent study in which participants judged a fictional GLP-1 user more negatively than someone who lost no weight at all — a striking finding that puts the cultural bias on full display. Topics covered: the "cheating" narrative, social circle influence, celebrity distortion, the gender gap in weight loss criticism, and why supporting someone's health journey — whatever form it takes — is always the right call. Rick and Greg are medical providers, but not your medical provider. Consult your personal provider before beginning any weight loss program, medication, or supplement.

Obesity Health Policy Update

In this episode, Rick and Greg discuss a groundbreaking 2026 policy statement from leading obesity organizations that redefines how obesity should be treated in modern medicine. The key takeaway: Obesity is a chronic, biologically driven disease—and it’s being significantly underdiagnosed and undertreated.   The new guidelines emphasize: * Earlier and more aggressive intervention * Combining lifestyle changes with medication, not delaying treatment * Strong evidence supporting the safety and effectiveness of long-term obesity medications * A shift away from focusing solely on weight toward broader health outcomes like cardiovascular risk, diabetes prevention, and overall quality of life Rick and Greg also highlight a critical reality: stopping treatment often leads to weight regain, reinforcing the need to view obesity like other chronic diseases that require ongoing management. This episode underscores a major shift in healthcare—from treating complications to addressing obesity at its root, earlier and more effectively.